Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) -2.417.3270.7146.60-54.32

What is the latest EBIT Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EBIT Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS is -2.41 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar2024-2.41
Mar20237.32
Mar202270.71
Mar202146.60
Mar2020-54.32

How is EBIT Growth of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2024 -2.41
Negative
Mar2023 7.32
-89.65
Mar2022 70.71
51.74
Mar2021 46.6
Positive
Mar2020 -54.32 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EBIT Growth ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹48,238.3 Cr -3.8% 2.6% 35% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,406.0 Cr -2.7% 3.9% 19.8% Stock Analytics
DIVIS LABORATORIES ₹163,113.0 Cr 1% 8.5% 55.3% Stock Analytics
CIPLA ₹121,869.0 Cr -2.6% 3.9% 6.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,345.0 Cr -0.7% 2.5% 22.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,801.0 Cr -1.9% 0.9% -7.8% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-3.8%

2.6%

35%

SENSEX

0.6%

6.2%

8.4%


You may also like the below Video Courses